(Q48765973)

15 February 2018

title

Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model (English)

1 reference

15 February 2018

1 reference

Kjell-Morten Myhr

1 reference

15 February 2018

Oivind Torkildsen

1 reference

15 February 2018

Lage Aksnes

object named as

Lage Aksnes

1 reference

15 February 2018

Stig Wergeland

object named as

Stig Wergeland

1 reference

15 February 2018

author name string

Agnes E Nystad

1 reference

15 February 2018

Lars Bø

1 reference

15 February 2018

publication date

26 May 2014

1 reference

15 February 2018

Acta Pathologica et Microbiologica Scandinavica

published in

1 reference

15 February 2018

volume

122

1 reference

15 February 2018

issue

1 reference

15 February 2018

page(s)

1178-1186

1 reference

15 February 2018

1 reference

A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q).

21 January 2018

1 reference

Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics

21 January 2018

1 reference

Vitamin D treatment in multiple sclerosis

21 January 2018

1 reference

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

21 January 2018

1 reference

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes.

21 January 2018

1 reference

Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination

21 January 2018

1 reference

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice

21 January 2018

1 reference

The cuprizone animal model: new insights into an old story

21 January 2018

1 reference

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

21 January 2018

1 reference

Vitamin D in multiple sclerosis: implications for assessment and treatment

21 January 2018

1 reference

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination

21 January 2018

1 reference

Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination.

21 January 2018

1 reference

Vitamin D as an immune modulator in multiple sclerosis, a review

21 January 2018

1 reference

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain

21 January 2018

1 reference

Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue

21 January 2018

1 reference

Microglia as neuroprotective, immunocompetent cells of the CNS.

21 January 2018

1 reference

Astrocytes in multiple sclerosis: a product of their environment

21 January 2018

1 reference

Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination

21 January 2018

1 reference

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

21 January 2018

1 reference

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APM.12281

1 reference

15 February 2018

1 reference

15 February 2018